yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38216215-392B9D96-BC11-4AF0-A036-9E9D8C33235D
Q38216215-392B9D96-BC11-4AF0-A036-9E9D8C33235D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38216215-392B9D96-BC11-4AF0-A036-9E9D8C33235D
Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX).
P2860
Q38216215-392B9D96-BC11-4AF0-A036-9E9D8C33235D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38216215-392B9D96-BC11-4AF0-A036-9E9D8C33235D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14b2d9c32f4edf8415c2b265c6dcd287acb18589
P2860
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial